Tuesday, August 23, 2016

Reminder: Congential Zika Virus Infection COCA Call Today











#11654

The CDC will host another in a series of COCA calls on Zika virus infection, and Zika Congenital Syndrome, this afternoon.

Primarily of interest to clinicians and healthcare providers, COCA (Clinician Outreach Communication Activity) calls are designed to ensure that practitioners have up-to-date information for their practices.

COCA calls are archived on the CDC's website, and may be accessed HERE, generally within a few days of airing.  Older presentations - going back to 2012 - are also available at that link.



Zika Update: Clinical Laboratory Testing and Care of Infants with Congenital Zika Virus Infection
 
 Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date:Tuesday, August 23, 2016

Time:2:00-3:00 pm (Eastern Time)

Participate by Phone:

    U.S. Callers: 888-982-4696
    International Callers: 415-228-4940

Passcode:1511429

Participate by Webinar: https://www.mymeetings.com/nc/join.php?i=PW9584378&p=1511429&t=c
Presenter(s)

Kate Russell, MD, MPH
Epidemic Intelligence Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Sara E. Oliver, MD, MSPH
Epidemic Intelligence Officer
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Overview

Zika virus infection during pregnancy is a cause of microcephaly and other severe fetal brain defects; however, the full spectrum of infant outcomes is not yet known. CDC has updated its interim guidance for U.S. healthcare providers caring for infants born to mothers with possible Zika virus infection during pregnancy. During this COCA Call, clinicians will learn about these updated interim clinical guidelines, which include evaluation and management recommendations. This information can help pediatric healthcare providers better understand the appropriate tests and clinical approaches for evaluating and managing infants, born to mothers in the United States and its territories, with laboratory evidence of Zika virus infection.


Objectives

  • Interpret revised testing guidance for newborns with possible congenital Zika virus infection.
  • Discuss clinical evaluation of infants born to mothers with laboratory evidence of Zika virus infection.
  • Outline outpatient management of infants with laboratory evidence of congenital Zika virus infection with and without  abnormalities consistent with congenital Zika syndrome.

Call Format

    Audio conference call on 8/23/16: 2:00 - 3:00 PM EDT
    Web-on-demand training after 3:00 PM EDT on 8/23/16
    Materials: PowerPoint slide set